Variant report
Variant | esv3392176 |
---|---|
Chromosome Location | chr5:93864196-93866194 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560058718 | chr5:93864214-93864215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147556107 | chr5:93864247-93864248 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576765378 | chr5:93864286-93864287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545353229 | chr5:93864317-93864318 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548573845 | chr5:93864396-93864397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562133373 | chr5:93864445-93864446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551789151 | chr5:93864463-93864464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189046690 | chr5:93864468-93864469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs80140645 | chr5:93864492-93864493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371001404 | chr5:93864493-93864494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs79731269 | chr5:93864494-93864495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531449260 | chr5:93864506-93864507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs72771693 | chr5:93864513-93864514 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs7702344 | chr5:93864514-93864515 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs182542386 | chr5:93864551-93864552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553693103 | chr5:93864560-93864561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561355705 | chr5:93864568-93864569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187117541 | chr5:93864599-93864600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567179946 | chr5:93864665-93864666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551206627 | chr5:93864676-93864677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535800902 | chr5:93864702-93864703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530277786 | chr5:93864703-93864704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142005557 | chr5:93864805-93864806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544672761 | chr5:93864806-93864807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558016211 | chr5:93864864-93864865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577406778 | chr5:93864900-93864901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150163815 | chr5:93864906-93864907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs138648018 | chr5:93864929-93864930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190425321 | chr5:93864945-93864946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs61345271 | chr5:93864949-93864950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs372624630 | chr5:93864951-93864952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546996477 | chr5:93864963-93864964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536733688 | chr5:93864973-93864974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs60444380 | chr5:93864980-93864981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556778211 | chr5:93864983-93864984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375744083 | chr5:93864994-93864995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532562242 | chr5:93864997-93864998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567120426 | chr5:93865000-93865001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs60078669 | chr5:93865008-93865009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148104229 | chr5:93865014-93865015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531232743 | chr5:93865023-93865024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs59681054 | chr5:93865025-93865026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs181536447 | chr5:93865031-93865032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs199725421 | chr5:93865036-93865037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185706698 | chr5:93865042-93865043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536157593 | chr5:93865050-93865051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs58103553 | chr5:93865058-93865059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533524441 | chr5:93865061-93865062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547217949 | chr5:93865063-93865064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs377248538 | chr5:93865068-93865069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:93849400-93872400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr5:93854800-93874800 | Weak transcription | Liver | Liver |
3 | chr5:93855400-93886400 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
4 | chr5:93856200-93882600 | Weak transcription | Ovary | ovary |
5 | chr5:93858400-93867800 | Weak transcription | Fetal Lung | lung |
6 | chr5:93863000-93864200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr5:93864200-93864400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |